Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
#ASCO26 truly embodied the theme of translating science into global patient outcomes. We are grateful to the ~46,000 attendees, all working tirelessly to conquer cancer together! A heartfelt thanks to all. 💗 We can’t wait to see you next year at #ASCO27!
Milestone unlocked: Our 50th endowed Young Investigator Award is funded!
It is with immense gratitude to our individual donors, foundations and organizations that we announce that Conquer Cancer has officially funded 50 endowed Young Investigator Awards. This milestone ensures that through these grants, 50 early-career researchers will receive dedicated funding each year into the future.
Read the announcement and learn what comes next: bit.ly/4igxrf3
ICYMI: Health insurers are initially denying most oral blood cancer Txs and prior auths are cited as the single largest hurdle to this potentially lifesaving care! Write to your lawmakers to urge them to #FixPriorAuth: bit.ly/4dRSOSs#ASCOAdvocacy
Read now in #JCO 👇
Insurance and Cost-Related Access Barriers to Specialty Oral Anticancer Medications for Blood Cancers in a Nationwide Sample of Medicare and Commercially Insured Patients.
Read the full article. bit.ly/4yIfZ9W
ASCO Leads: Latin America applications open! Apply by 10/26 to join us in Costa Rica Feb. 11-12, 2027, for leadership training & premier networking. Designed for mid-career ASCO Members currently practicing oncology in the Latin America region. Learn more: bit.ly/4ynK1ig
Our draft guideline recommendations for “Perioperative Systemic Therapy for Non-Metastatic Renal Cell Carcinoma” are now open for public comment. Help us refine these standards of care. Submit your comments to us by November 3.
Read and comment: bit.ly/4ylVcIj
The future of govt relations for @asco is bright! ⭐️And female! 🩷As immediate past chair of the #GRC govt relations cmte, it’s terrific to see Dr Joanna Yang as current chair & Dr Erin Schwab as incoming chair. So much talent! #advocacy
This is why I love these meetings! Great to run into an amazing mentor and leader at @ASCO
Wonderful day 1 of chiefs and chairs leadership development day!
Looking forward to day 2
@UMMC_Cancer@UMMCnews
Learning lots of practical and strategic wisdom in leadership and team building at the Inaugural ASCO Leads - Program for Oncology Division Chiefs and Department Chairs 10/19 - 10/20/26 at the ASCO Headquarter. @ASCO@LSU
ASCO Members! You now get full access to ASCO Meetings content 30 days post-meeting. Explore the latest science faster! View content from the 2026 ASCO Annual Meeting: bit.ly/4hXg1DS
Coming soon: An AI-powered agent from ASCO & Google Cloud to simplify your research.
Our draft guideline recommendations for “Management of Immune-Related Adverse Events- Gastrointestinal and Endocrine Toxicities” are now open for public comment.
Submit your comments to us by November 2: bit.ly/4i6DUck
What a wonderful #ASCOQLTY26!
From PROs, AI & #SuppCare to health equity, implementation science & patient-centered care!
THANK YOU to all @ASCO staff, speakers, presenters & attendees who made this meeting so special! 👏
Congratulation @RyanNipp on a record-breaking 1,000+ attendees!
Looking forward to #ASCOQLTY27 w @WhatsUrHari as Chair!
It was a pleasure to attend my first @ASCO Quality Care Symposium this weekend in Boston! I had the opportunity to present my work with Dr. Simmons at BC Cancer on quality indicators for breast cancer care and learn from inspiring presenters advancing cancer care. #ASCOQLTY2026
Back at @ASCO HQ for the first time since before COVID!
Our Government Relations Committee works to advance cancer research funding, sustainable Medicare payment, less prior authorization burden & better access to care.
Good cancer policy is essential to good cancer care.
ALT ASCO headquarters building in Alexandria, Virginia.
The last session has ended, and our time at #ASCOQLTY26 has come to a close.
Thank you to our incredible attendees, speakers, and patient advocates for coming together to share actionable insights, elevate care delivery, and improve outcomes for the cancer community. 🧡
Dr. @crisbergerot and Dr. @angelamferaco chair a session examining systems-level care solutions & clinical models that personalize treatment for diverse patient populations, including AYAs and older adults at #ASCOQLTY26. bit.ly/4jOLWsE
Breast cancer survivorship care goes beyond surveillance!
At #ASCOQLTY26, a promising, scalable interdisciplinary survivorship care model highlights the value of addressing the physical, emotional & practical needs of breast cancer survivors.
Congrats to @AGovindarajanMD on his Conquer Cancer Merit Award at #ASCOQLTY26 I'm a proud co-author w @ACSLungCancerRT Survivorship Task Group Across 51 NCI centers, 82% offer survivorship programs, but models vary widely, and funding is the top barrier #lcsm#SurvOnc#HOFellows
ALT Dr. Ameish Govindarajan stands beside poster board A10, marked with a Conquer Cancer Merit Award sign, at the ASCO Quality Care Symposium. His Cleveland Clinic poster is titled “Who, what, when: A national survey of survivorship care delivery at US cancer centers.”